Published in Pharmacogenetics on April 01, 2001
Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol (2003) 1.13
Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.09
Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors. Br J Pharmacol (2004) 0.96
The functional significance of genetic variation within the beta-adrenoceptor. Br J Clin Pharmacol (2005) 0.93
Race, common genetic variation, and therapeutic response disparities in heart failure. JACC Heart Fail (2014) 0.91
Arg389Gly β1-adrenergic receptor polymorphism and susceptibility to syncope during tilt test. Arch Med Sci (2014) 0.82
Functional effects of β₁-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration. Clin Res Cardiol (2010) 0.78
The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications. World J Cardiol (2010) 0.77
Physiological significance of beta-adrenergic receptor polymorphisms: in-vivo or in-vitro veritas? Pharmacogenetics (2001) 0.77
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure. Clin Med Insights Cardiol (2011) 0.75
Genomic ancestry as a predictor of haemodynamic profile in heart failure. Open Heart (2016) 0.75
Receptor gene polymorphisms: lessons on functional relevance from the beta 1-adrenoceptor. Br J Pharmacol (2003) 0.75
Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis PotosÍ and León, México. J Biomed Res (2016) 0.75
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med (1981) 3.98
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest (1998) 3.66
Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol (1985) 3.62
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin Pharmacol Ther (2011) 3.53
Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med (1995) 3.25
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Cloned DNA probes regionally mapped to human chromosome 21 and their use in determining the origin of nondisjunction. Nucleic Acids Res (1985) 3.09
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Racial differences in the response to drugs--pointers to genetic differences. N Engl J Med (2001) 2.90
Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol (2001) 2.86
Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther (1979) 2.85
Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res (1986) 2.77
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med (2001) 2.74
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther (2013) 2.73
Bone-anchored hearing aids for people with bilateral hearing impairment: a systematic review. Clin Otolaryngol (2011) 2.58
Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther (2007) 2.52
The Dehydrogenation of Alcohols by Streptococci of Group B. J Bacteriol (1942) 2.46
Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem (2001) 2.42
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling. Clin Pharmacol Ther (1979) 2.31
Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med (1989) 2.29
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics (2001) 2.29
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res (1999) 2.24
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction. JAMA (1995) 2.18
The role of membranes in the ogranization of the mitotic apparatus. Exp Cell Res (1975) 2.06
Fetal bradycardia and uterine hyperactivity following subarachnoid administration of fentanyl during labor. Reg Anesth (1997) 2.04
Atypical myoglobinuria alert. Vet Rec (1990) 2.02
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos (1999) 2.02
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]. Circulation (1999) 2.01
Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature (1990) 1.99
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther (2013) 1.99
The cell cycle genes cdc22+ and suc22+ of the fission yeast Schizosaccharomyces pombe encode the large and small subunits of ribonucleotide reductase. Mol Gen Genet (1993) 1.88
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
Drug-induced haemolysis masquerading as blackwater fever. Cent Afr J Med (1987) 1.82
Effect of low temperature on fatty acid biosynthesis in seeds. Biochim Biophys Acta (1969) 1.77
Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75
Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax (1967) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem (2001) 1.67
Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation (1998) 1.64
Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol (1977) 1.64
The effect of low temperatures on fatty acid biosynthesis in plants. Biochem J (1969) 1.63
Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol (1975) 1.63
Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther (1979) 1.62
Distribution of tubulin-containing structures in the egg of the sea urchin Strongylocentrotus purpuratus from fertilization through first cleavage. J Cell Biol (1980) 1.60
Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol (1978) 1.60
Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther (2000) 1.60
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford) (2008) 1.59
Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol (2001) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. BMJ (2011) 1.55
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther (1979) 1.55
Identification of a locus which shows no genetic recombination with the autosomal dominant polycystic kidney disease gene on chromosome 16. Am J Hum Genet (1990) 1.52
Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol Cell (2001) 1.52
The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation. Health Technol Assess (2010) 1.51
Post-mortem size and structure of the human carotid body. Thorax (1970) 1.50
Pain on injection: a double-blind comparison of propofol with lidocaine pretreatment versus propofol formulated with long- and medium-chain triglycerides. Anesth Analg (2004) 1.49
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin Pharmacol Ther (1989) 1.48
Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. Int J Obstet Anesth (2010) 1.47
The carotid body in animals at high altitude. J Pathol (1971) 1.46
Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol (2008) 1.46
Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance. Anesthesiology (1992) 1.46
The Ovarian Tumor Index predicts risk for malignancy. Cancer (1999) 1.45
Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet (1997) 1.45
The carotid body in emphysema and left ventricular hypertrophy. J Pathol (1971) 1.45
Indications for fenestrated endovascular aneurysm repair. Br J Surg (2012) 1.43
Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med (1982) 1.43
Propranolol withdrawal syndrome - why? Circulation (1978) 1.43
CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism. Clin Pharmacol Ther (2000) 1.42
Dinucleotide repeat polymorphisms at the D16S164, D16S168 and D16S186 loci at 16q21-q22.1. Nucleic Acids Res (1991) 1.42
Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus. Lupus (2011) 1.41
Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial. Med Care (2001) 1.41
Determination of the DNA content of human chromosomes by flow cytometry. Cytogenet Cell Genet (1986) 1.40
Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther (1991) 1.39
Teaching on the run: teaching skills for surgical trainees. Aust N Z J Surg (2000) 1.39
Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity. Hypertension (2000) 1.38
BSE in Great Britain: consistency of the neurohistopathological findings in two random annual samples of clinically suspect cases. Vet Rec (1996) 1.38
Implementation of nationally developed guidelines in cardiology: a survey of NSW cardiologists and cardiothoracic surgeons. Aust N Z J Med (1999) 1.38
Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med (1985) 1.37
Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart (2007) 1.36
Role of delayed hypersensitivity in predicting postoperative morbidity and mortality. Am J Surg (1979) 1.36
Biological determinants of propranolol disposition in man. Clin Pharmacol Ther (1978) 1.35
Parenthood following renal and hepatic transplantation. Transplantation (1980) 1.35
The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. Cardiovasc Res (1968) 1.34
Short stature and chronic renal failure: what concerns children and parents? Arch Dis Child (1995) 1.34
A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther (2003) 1.34